Actionable news
0
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

AbbVie's Venclexta Receives Accelerated Approval From FDA, Stock Ticks Higher

Trade with confidence. Are you a professional trader? Be the first to get the alert with Benzinga Pro's real-time newsfeed and audio squawk and never miss an opportunity again.
Don't miss the chance to try it FREE today.

ABBV - AbbVie's Venclexta Receives Accelerated Approval From FDA, Stock Ticks Higher

Shares of AbbVie Inc ABBV were trading higher by nearly 2 percent early Tuesday morning after the company announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Venclexta.

Venclexta, a table taken orally, is used for the treatment of patients diagnosed with chronic lymphocytic...


More